Results

Total Results: 1,887 records

Showing results for "testing".

  1. effectivehealthcare.ahrq.gov/sites/default/files/considerations-for-statistical-chapter-10.pptx
    January 01, 2013 - Univariate or unadjusted hypothesis testing, such as two-sample t-tests, can be conducted to identify … Unadjusted Analysis Univariate or unadjusted hypothesis testing, such as two-sample t-tests, can be conducted … This assessment can include, but is not limited to, testing for differences in study covariates by exposure
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
    September 30, 2010 - Pulsegen device Certificate of Approval for Use of GS Symbol No. 95 44 083; LGA, Equipment Safety Testing … Pad testing: The amount of urine lost during incontinence episodes (comparison of a short provocative
  3. effectivehealthcare.ahrq.gov/products/methods-guidance-tests-grading/slides
  4. effectivehealthcare.ahrq.gov/products/methods-guidance-tests-introduction/slides
  5. effectivehealthcare.ahrq.gov/products/breast-abnormalities-tests/research
  6. effectivehealthcare.ahrq.gov/products/cancer-pancreas/research
  7. effectivehealthcare.ahrq.gov/products/cancer-pancreas/research-protocol
  8. effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
    October 30, 2012 - The process of developing and testing a new PRO measure can be lengthy—generally requiring at least … Item Response Theory (IRT) and Computer Adaptive Testing (CAT) Item Response Theory (IRT) is a framework … Computer Adaptive Testing (CAT) represents an area of innovation in measuring PROs. … Testing other measurement properties will not replace or rectify problems with content validity.18 … The blood testing program was implemented to detect early development of agranulocytemia.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
    January 01, 2010 - particular wards, units, or patients (targeted screening) that includes: • MRSA screening using a testing … is performed) or • MRSA screening using a testing modality with intermediate turnaround (results … available next day to 2 days after testing performed) or • MRSA screening using a testing modality … (typically culture) with a longer turnaround time (results available more than 2 days after testing … The cluster RCT is increasingly recognized as the optimal design for testing and evaluating the impact
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-5.pdf
    February 01, 2018 - cautiously because confidence interval overlap is not a reliable substitute for formal hypothesis testing
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
    August 01, 2014 - Panel revealed considerable uncertainty about the reliability of procalcitonin measured with newer testing … properties of a diagnostic test (e.g. sensitivity, specificity, predictive values) may vary across testing … It extends from basic testing principles (Level 1) through clinical applications in diagnosis (Levels … whether to start antibiotics, and other questions addressing whether to do sequential procalcitonin testing … Study populations at institutions or individual practices that do not offer procalcitonin testing may
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias_methods.pdf
    February 01, 2013 - for comparative effectiveness reviews ................. 15 1 Key Points • One hypothesis-testing … For example, cognitive testing using laboratory settings. … after deciding to include observational studies, EPCs need to take special care in developing and testingTesting of inter- or intra-rater reliability, using the kappa statistic is sometimes suggested as a … achieve perfect agreement, and using the usual dual review process should obviate the need for such testing
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
    April 01, 2013 - Future studies testing these longer timeframes for discontinuing preventive pharmacologic treatment … However, continued consultations among researchers and providers along with continued field testing … Future 17 studies testing these longer timeframes for discontinuing preventive pharmacologic … A large sample capable of testing these characteristics via subgroup differences is necessary. … A large sample capable of testing these characteristics via subgroup differences is necessary.
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
    September 01, 2012 - Appendix A Figure 1 outlines the proposed approach and its validity testing in detail. … The first approach (―Augmented MeSH Approach‖) had achieved good performance in testing on drug comparative … education in which project staff coached practice staff in reviewing performance and identifying, testing … Reason: Setting (not health care delivery organization) Field testing of the ACCESS materials: … The field testing of this portfolio is reported here.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
    November 12, 2013 - surveillance can cause anxiety about not treating the condition, inconvenience associated with regular testing … health care consumers and their providers engage in shared decisionmaking when facing screening, other testing … developmental process include (1) scoping and design, (2) developing a prototype, (3) an iterative “alpha” testing … phase with patients and clinicians, (4) “beta” testing in real-life conditions, and (5) production … support a review A large number of people face decisions about cancer screening, treatment, or other testing
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research.pdf
    June 01, 2017 - Treatment-emergent adverse events (TEAEs), otoscopy for the presence of bilateral effusion, audiometric testing … Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
    August 11, 2014 - are differences in results between “registry” studies that used different local labs under routine testing … nephrologists, emergency room physicians, and laboratory medicine scientists who use and interpret troponin testing
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
    October 26, 2012 - Analytic Framework From CER for CDI Diagnostic Testing, Prevention, and Treatment ................. … Analytic Framework From CER for CDI Diagnostic Testing, Prevention, and Treatment ................. … diagnostic methods were not included in this project primarily because polymerase chain reaction testing … Analytic framework from CER for CDI diagnostic testing, prevention, and treatment KQ3 KQ4 … Analytic framework from CER for CDI diagnostic testing, prevention, and treatment KQ3 KQ4
  19. effectivehealthcare.ahrq.gov/products/kidney-stone-imaging/consumer
  20. effectivehealthcare.ahrq.gov/products/methods-guidance-tests-grading/methods

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: